+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Azithromycin Market - Global Forecast 2026-2032- Product Image
Azithromycin Market - Global Forecast 2026-2032- Product Image
Sale

Azithromycin Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082440
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Azithromycin Market is projected to reach USD 8.28 Billion in 2026. It is expected to continue growing at a CAGR of 5.88%, reaching USD 11.68 Billion by 2032.

Azithromycin: Executive Overview of Clinical Use and Market Dynamics

Azithromycin is a macrolide antibiotic used against selected susceptible bacterial infections, including respiratory, skin and soft-tissue, sexually transmitted, and certain enteric infections. Its extended tissue persistence, relatively convenient dosing, and availability in oral and intravenous forms have supported broad clinical adoption. However, its appropriate role is increasingly defined by antimicrobial-resistance patterns, local treatment guidelines, diagnostic capacity, and stewardship requirements rather than convenience alone.

Stewardship, Resistance, and Formulation Needs Are Reshaping Azithromycin Use

The azithromycin landscape is being transformed by efforts to reduce unnecessary antibiotic exposure and preserve effectiveness. Rising resistance among important respiratory and sexually transmitted pathogens has encouraged greater reliance on microbiological testing, susceptibility surveillance, and guideline-based prescribing. At the same time, demand for pediatric formulations, simplified dosing regimens, reliable supply, and quality-assured generic products remains relevant, particularly where healthcare access is uneven. Regulatory scrutiny and pharmacovigilance also continue to emphasize appropriate indications, drug interactions, and cardiac safety considerations in at-risk patients.

Artificial Intelligence Can Improve Azithromycin Stewardship, Surveillance, and Supply Planning

Artificial intelligence can support azithromycin management by analyzing clinical records, laboratory results, prescribing patterns, and resistance data to identify cases in which treatment may be unnecessary or poorly targeted. Predictive tools may help laboratories and public-health agencies detect geographic or pathogen-specific resistance signals earlier, while decision-support systems can reinforce dosing, contraindication, and interaction checks. Applications in demand planning and quality monitoring may improve product availability, but implementation requires representative data, clinical validation, transparency, privacy safeguards, and human oversight to avoid amplifying prescribing bias or producing unsafe recommendations.

Regional Priorities Differ Across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific

North America is characterized by mature stewardship programs, extensive diagnostic infrastructure, and close attention to resistance and cardiac-risk guidance. Latin America continues to balance broad access to essential antibiotics with uneven regulation, self-medication risks, and variable surveillance. Europe emphasizes antimicrobial stewardship, coordinated resistance monitoring, and alignment with evidence-based treatment guidance. The Middle East faces diverse healthcare systems, cross-border care, and the need to strengthen prescribing controls and laboratory capacity. Africa’s priorities include reliable access to quality-assured medicines, diagnosis of febrile illness, supply continuity, and expanded resistance surveillance. Asia-Pacific combines substantial clinical demand with highly varied regulatory environments, urban healthcare capacity, and persistent challenges involving over-the-counter access and resistance containment.

ASEAN, BRICS, the European Union, G7, GCC, and NATO Highlight Different Coordination Needs

ASEAN countries can benefit from harmonized stewardship practices, stronger cross-border surveillance, and improved access to pediatric and quality-assured formulations. BRICS members encompass major differences in disease burden, manufacturing capacity, regulation, and laboratory networks, making coordinated resistance-data standards especially valuable. The European Union supports shared surveillance and antimicrobial policy approaches, while the G7 can prioritize research cooperation, supply-chain resilience, and responsible use. GCC countries have opportunities to align procurement, prescribing controls, and regional monitoring across interconnected health systems. NATO members, whose healthcare priorities span civilian and operational settings, can strengthen preparedness through interoperable surveillance, resilient medical supply arrangements, and consistent stewardship principles.

Country-Level Priorities Span Access, Resistance Monitoring, Regulation, and Clinical Guidance

Australia and Canada emphasize stewardship, surveillance, and evidence-based prescribing across geographically dispersed systems. Brazil, Mexico, India, China, and Russia must address large and diverse populations, variable access, and resistance monitoring while strengthening regulatory enforcement and diagnostic capacity. France, Germany, Italy, Spain, and the United Kingdom continue to focus on reducing inappropriate antibiotic use, maintaining surveillance, and integrating azithromycin into updated national guidance. Japan and South Korea combine advanced healthcare infrastructure with close attention to resistance trends, safety monitoring, and precision prescribing. Across the United States, priorities include outpatient stewardship, resistance surveillance, appropriate use in vulnerable patients, and reliable access to quality-assured formulations.

Industry Leaders Should Align Azithromycin Strategy With Stewardship and Evidence

Leaders should prioritize products and services that address documented clinical needs, including age-appropriate formulations, dependable quality, and clear prescribing information. They should support independent resistance surveillance, diagnostic access, clinician education, and partnerships with public-health systems rather than relying on volume-driven antibiotic use. Supply planning should include diversified sourcing, quality controls, and contingency arrangements for essential formulations. Digital and AI-enabled tools should be introduced with clinical validation, explainability, cybersecurity, and post-deployment monitoring. Any lifecycle strategy should also incorporate pharmacovigilance, transparent medical communication, and alignment with national and regional treatment guidelines.

Research Methodology for a Data-Driven Azithromycin Executive Summary

This summary uses a structured synthesis of authoritative clinical guidelines, regulatory safety communications, antimicrobial-resistance surveillance, public-health publications, peer-reviewed research, and health-system stewardship frameworks. Evidence was interpreted qualitatively across the specified regions, country groups, and countries, with attention to differences in healthcare access, regulation, diagnostics, resistance patterns, and medicine supply. Claims were limited to established clinical and policy considerations; no market estimates, market shares, forecasts, or company-specific assessments were used. Because resistance and treatment guidance change over time, conclusions should be reviewed against current local protocols and surveillance data.

Azithromycin’s Future Depends on Appropriate Use, Resistance Intelligence, and Reliable Access

Azithromycin remains clinically relevant when used for susceptible infections and in accordance with current guidance, but its value depends on preserving effectiveness and minimizing avoidable exposure. Regional and country differences make local surveillance, diagnostics, regulation, and supply resilience essential. The strongest long-term approach combines responsible access with stewardship, safety monitoring, validated digital support, and collaboration among clinicians, laboratories, regulators, and public-health authorities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Azithromycin Market, by Product Type
7.1. Introduction
7.2. Branded
7.3. Generic
8. Azithromycin Market, by Dosage Form
8.1. Introduction
8.2. Capsule
8.3. Suspension
8.4. Tablet
9. Azithromycin Market, by Route Of Administration
9.1. Introduction
9.2. Intravenous
9.3. Oral
10. Azithromycin Market, by Indication
10.1. Introduction
10.2. Gastrointestinal Infections
10.3. Respiratory Infections
10.3.1. Lower Respiratory Infections
10.3.2. Upper Respiratory Infections
10.4. Sexually Transmitted Infections
10.4.1. Chlamydia Infections
10.4.2. Gonorrhea
10.5. Skin Infections
10.5.1. Acute Bacterial Skin Structure Infections
10.5.2. Soft Tissue Infections
11. Azithromycin Market, by End User
11.1. Introduction
11.2. Ambulatory Care
11.3. Clinics
11.4. Homecare
11.5. Hospitals
12. Azithromycin Market, by Sales Channel
12.1. Introduction
12.2. Drug Store
12.3. Hospital Pharmacy
12.4. Online Pharmacy
12.5. Retail Pharmacy
13. Azithromycin Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Azithromycin Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Azithromycin Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aurobindo Pharma
17.2. Cipla Ltd.
17.3. Dr. Reddy's Laboratories Ltd.
17.4. Hikma Pharmaceuticals PLC
17.5. Lupin Limited
17.6. Lupin Limited
17.7. Pfizer Inc.
17.8. Sandoz International GmbH
17.9. Sun Pharmaceutical Industries Ltd.
17.10. Teva Pharmaceutical Industries Ltd.
17.11. Viatris Inc.
17.12. Zydus Lifesciences Ltd.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Azithromycin Market, Years Considered for the Study
FIGURE 2. Global Azithromycin Market, Research Design
FIGURE 3. Global Azithromycin Market, Research Framework
FIGURE 4. Global Azithromycin Market, Data Triangulation
FIGURE 5. Global Azithromycin Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Azithromycin Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Azithromycin Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Azithromycin Market Size, by Dosage Form, 2025 vs 2032 (%)
FIGURE 9. Global Azithromycin Market Size, by Dosage Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Azithromycin Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Azithromycin Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Azithromycin Market Size, by Indication, 2025 vs 2032 (%)
FIGURE 13. Global Azithromycin Market Size, by Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Azithromycin Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Azithromycin Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Azithromycin Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 17. Global Azithromycin Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Azithromycin Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Azithromycin Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Azithromycin Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Azithromycin Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Azithromycin Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Azithromycin Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Azithromycin Market Segmentation & Coverage
TABLE 2. Global Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 3. Global Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Branded Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Branded Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Branded Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Generic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Generic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Generic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 11. Global Capsule Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Capsule Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Capsule Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Suspension Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Suspension Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Suspension Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Tablet Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Tablet Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Tablet Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 21. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 28. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Lower Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Lower Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Lower Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Upper Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Upper Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Upper Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Sexually Transmitted Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Sexually Transmitted Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Sexually Transmitted Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Chlamydia Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Chlamydia Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Chlamydia Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Gonorrhea Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Gonorrhea Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Gonorrhea Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Skin Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Skin Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Skin Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Acute Bacterial Skin Structure Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Acute Bacterial Skin Structure Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Acute Bacterial Skin Structure Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Soft Tissue Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Soft Tissue Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Soft Tissue Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Global Ambulatory Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Ambulatory Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Ambulatory Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Homecare Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Homecare Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Homecare Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 72. Global Drug Store Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Drug Store Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Drug Store Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Hospital Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Hospital Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Hospital Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Online Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Online Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Online Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Retail Pharmacy Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Retail Pharmacy Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Retail Pharmacy Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 88. Asia-Pacific Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 89. Asia-Pacific Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 90. Asia-Pacific Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 91. Asia-Pacific Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 92. Asia-Pacific Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 93. Asia-Pacific Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Asia-Pacific Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 95. North America Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. North America Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. North America Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 98. North America Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 99. North America Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 100. North America Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 101. North America Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 102. North America Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 103. North America Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. North America Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 105. Latin America Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Latin America Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 107. Latin America Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 108. Latin America Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 109. Latin America Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 110. Latin America Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 111. Latin America Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 112. Latin America Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 113. Latin America Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Latin America Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 115. Europe Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Europe Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. Europe Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 118. Europe Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 119. Europe Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 120. Europe Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 121. Europe Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 122. Europe Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 123. Europe Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 124. Europe Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 125. Middle East Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Middle East Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 127. Middle East Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 128. Middle East Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 129. Middle East Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 130. Middle East Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 131. Middle East Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 132. Middle East Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 133. Middle East Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Middle East Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 135. Africa Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Africa Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 137. Africa Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 138. Africa Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 139. Africa Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 140. Africa Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 141. Africa Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 142. Africa Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 143. Africa Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 144. Africa Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 145. Global Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. ASEAN Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. ASEAN Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. ASEAN Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 149. ASEAN Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 150. ASEAN Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 151. ASEAN Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 152. ASEAN Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 153. ASEAN Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 154. ASEAN Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 155. ASEAN Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 156. GCC Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 157. GCC Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. GCC Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 159. GCC Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 160. GCC Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 161. GCC Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 162. GCC Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 163. GCC Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 164. GCC Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. GCC Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 166. European Union Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 167. European Union Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. European Union Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 169. European Union Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 170. European Union Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 171. European Union Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 172. European Union Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 173. European Union Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 174. European Union Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 175. European Union Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 176. BRICS Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. BRICS Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. BRICS Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 179. BRICS Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 180. BRICS Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 181. BRICS Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 182. BRICS Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 183. BRICS Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 184. BRICS Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 185. BRICS Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 186. G7 Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. G7 Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 188. G7 Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 189. G7 Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 190. G7 Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 191. G7 Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 192. G7 Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 193. G7 Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 194. G7 Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. G7 Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 196. NATO Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 197. NATO Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. NATO Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 199. NATO Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 200. NATO Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 201. NATO Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 202. NATO Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 203. NATO Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 204. NATO Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 205. NATO Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 206. Global Azithromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 207. United States Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 208. United States Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 209. United States Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 210. United States Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 211. United States Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 212. United States Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 213. United States Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 214. United States Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 215. United States Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. United States Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 217. Canada Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 218. Canada Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 219. Canada Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 220. Canada Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 221. Canada Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 222. Canada Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 223. Canada Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 224. Canada Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 225. Canada Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Canada Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 227. Mexico Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 228. Mexico Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 229. Mexico Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 230. Mexico Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 231. Mexico Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 232. Mexico Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 233. Mexico Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 234. Mexico Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 235. Mexico Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. Mexico Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 237. Brazil Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 238. Brazil Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 239. Brazil Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 240. Brazil Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 241. Brazil Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 242. Brazil Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 243. Brazil Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 244. Brazil Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 245. Brazil Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Brazil Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 247. United Kingdom Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 248. United Kingdom Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 249. United Kingdom Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 250. United Kingdom Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 251. United Kingdom Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 252. United Kingdom Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 253. United Kingdom Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 254. United Kingdom Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 255. United Kingdom Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. United Kingdom Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 257. Germany Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 258. Germany Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. Germany Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 260. Germany Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 261. Germany Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 262. Germany Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 263. Germany Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 264. Germany Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 265. Germany Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. Germany Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 267. France Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 268. France Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 269. France Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 270. France Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 271. France Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 272. France Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 273. France Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 274. France Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 275. France Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. France Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 277. Russia Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 278. Russia Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. Russia Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 280. Russia Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 281. Russia Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 282. Russia Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 283. Russia Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 284. Russia Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 285. Russia Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Russia Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 287. Italy Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 288. Italy Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 289. Italy Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 290. Italy Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 291. Italy Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 292. Italy Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 293. Italy Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 294. Italy Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 295. Italy Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 296. Italy Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 297. Spain Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 298. Spain Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 299. Spain Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 300. Spain Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 301. Spain Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 302. Spain Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 303. Spain Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 304. Spain Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 305. Spain Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 306. Spain Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 307. China Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 308. China Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. China Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 310. China Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 311. China Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 312. China Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 313. China Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 314. China Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 315. China Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 316. China Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 317. India Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 318. India Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 319. India Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 320. India Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 321. India Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 322. India Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 323. India Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 324. India Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 325. India Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. India Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 327. Japan Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 328. Japan Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 329. Japan Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 330. Japan Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 331. Japan Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 332. Japan Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 333. Japan Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 334. Japan Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 335. Japan Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Japan Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 337. Australia Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 338. Australia Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 339. Australia Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 340. Australia Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 341. Australia Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 342. Australia Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 343. Australia Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 344. Australia Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 345. Australia Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 346. Australia Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 347. South Korea Azithromycin Market Size, 2017-2032 (USD Million)
TABLE 348. South Korea Azithromycin Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 349. South Korea Azithromycin Market Size, by Dosage Form, 2017-2032 (USD Million)
TABLE 350. South Korea Azithromycin Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 351. South Korea Azithromycin Market Size, by Indication, 2017-2032 (USD Million)
TABLE 352. South Korea Azithromycin Market Size, by Respiratory Infections, 2017-2032 (USD Million)
TABLE 353. South Korea Azithromycin Market Size, by Sexually Transmitted Infections, 2017-2032 (USD Million)
TABLE 354. South Korea Azithromycin Market Size, by Skin Infections, 2017-2032 (USD Million)
TABLE 355. South Korea Azithromycin Market Size, by End User, 2017-2032 (USD Million)
TABLE 356. South Korea Azithromycin Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 357. Global Azithromycin Market Share, by Key Player, 2025
TABLE 358. Global Azithromycin Market, Key Experts

Companies Mentioned

  • Aurobindo Pharma
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Lupin Limited
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Related Topics

Related Reports

Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
India Azithromycin Market, By Region, Competition, Forecast and Opportunities, 2020-2030F - Product Image

India Azithromycin Market, By Region, Competition, Forecast and Opportunities, 2020-2030F

  • Report
  • 88 Pages
  • India
From
Macrolide Antibiotics Market Report 2026 - Product Image

Macrolide Antibiotics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Babesiosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Babesiosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From

About the Azithromycin Market

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics. Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients. The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.